This event has concluded, but exciting conferences are happening worldwide — explore upcoming events in your field and stay ahead with the latest insights and networking opportunities. Subscribe to our newsletter.

9th Annual Innate Killer Summit

109 109 people viewed this event.

Advancing NK Engager, Bispecific, Cell Therapy and Cytokine-based Approaches to the Clinic, Improving Clinical Durability and Streamlining Manufacture to Realise the Potential of NK Therapies

Time: 8:00 AM – 5:00 PM

Venue Details: San Diego Marriott Del Mar, 11966 El Camino Real, San Diego, California, 92130, United States

Speakers: Allen Feng, Founder and Chief Scientific Officer, HebeCell, Dan Kaufman, Professor/Co-founder, University of California San Diego / Shoreline Biosciences, Emilie Gauthy, Head of CMC, Zelluna Immunotherapy, Fred Aslan, CEO, Artiva Biotherapeutics, Johan Liwing, CEO, XNK Therapeutics, Juliana Vergara, Principal Scientist, Senti Bio, Mark Frohlich, Chief Executive Officer, Indapta Therapeutics, Raphael Ognar, CEO, NKILT Therapeutics, Robert Igarashi, Head of Discovery, Sanof

Event Organizer - Hanson Wade

Event Website
 

Date

18–20 March 2024
 

Country

United States of America
 

Topic Area

Health and Medicine

Share With Colleagues